PREVENTION OF CARDIOVASCULAR EVENTS (EG, DEATH FROM HEART OR VASCULAR DISEASE, HEART ATTACK, OR STROKE) IN PATIENTS WITH PRIOR HEART ATTACK USING TICAGRELOR COMPARED TO PLACEBO ON A BACKGROUND OF ASPIRIN: